Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$659M |
| 2 |
eBay
EBAY
|
+$230M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$205M |
| 4 |
Wynn Resorts
WYNN
|
+$197M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$195M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$441M |
| 2 |
Comcast
CMCSA
|
+$215M |
| 3 |
iShares US Real Estate ETF
IYR
|
+$203M |
| 4 |
Weyerhaeuser
WY
|
+$137M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$136M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.49% |
| 2 | Energy | 5.29% |
| 3 | Technology | 4.48% |
| 4 | Financials | 3.44% |
| 5 | Consumer Discretionary | 3.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBR
4051
Sabine Royalty Trust
SBR
$1.07B
| $393K | ﹤0.01% |
7,302
-317
| -4% | -$18K |
|
4052
Spectrum Brands
SPB
$2.07B
| $393K | ﹤0.01% |
4,368
-8,615
| -66% | -$740K |
|
|
CVD
4053
DELISTED
COVANCE INC.
CVD
| $393K | ﹤0.01% |
5,028
-11,656
| -70% | -$990K |
|
|
OREX
4054
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $393K | ﹤0.01% |
9,807
-8,023
| -45% | -$431K |
|
4055
CALL
Armstrong World Industries
AWI
$7.67B
| $392K | ﹤0.01% |
+7,000
| New | +$390K |
|
4056
CALL
ProShares UltraShort Dow 30
DXD
$42.7M
| $391K | ﹤0.01% |
815
+100
| +14% | +$49.9K |
|
|
FISV
4057
CALL
Fiserv Inc
FISV
$28.9B
| $391K | ﹤0.01% |
12,200
-5,600
| -31% | -$177K |
|
4058
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $391K | ﹤0.01% |
10,340
| – | – |
|
|
TUMI
4059
DELISTED
TUMI HLDGS INC COM
TUMI
| $391K | ﹤0.01% |
19,474
+4,351
| +29% | +$92.3K |
|
|
ATML
4060
CALL
DELISTED
ATMEL CORP
ATML
| $391K | ﹤0.01% |
48,800
-302,500
| -86% | -$2.62M |
|
|
PNY
4061
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $391K | ﹤0.01% |
11,821
-3,548
| -23% | -$127K |
|
4062
PUT
Curtiss-Wright
CW
$25.5B
| $390K | ﹤0.01% |
6,000
+5,100
| +567% | +$343K |
|
4063
PUT
Intrepid Potash
IPI
$493M
| $390K | ﹤0.01% |
2,600
-150
| -5% | -$23.1K |
|
4064
PUT
Trimble
TRMB
$13B
| $390K | ﹤0.01% |
13,000
-300
| -2% | -$9.75K |
|
|
XONE
4065
CALL
DELISTED
The ExOne Company
XONE
| $390K | ﹤0.01% |
19,500
-200
| -1% | -$6.11K |
|
|
POM
4066
PUT
DELISTED
PEPCO HOLDINGS, INC.
POM
| $390K | ﹤0.01% |
15,000
-200
| -1% | -$5.45K |
|
4067
CALL
Calix
CALX
$2.49B
| $389K | ﹤0.01% |
43,200
| – | – |
|
4068
CALL
Everest Group
EG
$14.1B
| $389K | ﹤0.01% |
2,400
+1,600
| +200% | +$259K |
|
4069
CALL
Group 1 Automotive
GPI
$3.12B
| $389K | ﹤0.01% |
5,400
-3,900
| -42% | -$304K |
|
4070
PUT
Logitech
LOGI
$14.8B
| $389K | ﹤0.01% |
32,400
+28,400
| +710% | +$386K |
|
4071
CALL
Invesco CurrencyShares Swiss Franc Trust
FXF
$397M
| $388K | ﹤0.01% |
3,800
-700
| -16% | -$74.8K |
|
4072
PUT
ITT
ITT
$19.6B
| $387K | ﹤0.01% |
8,800
-8,600
| -49% | -$409K |
|
4073
CALL
ResMed
RMD
$32.8B
| $387K | ﹤0.01% |
7,900
-16,000
| -67% | -$815K |
|
|
HTS
4074
PUT
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $387K | ﹤0.01% |
22,800
+12,700
| +126% | +$247K |
|
4075
PUT
Magna International
MGA
$18.7B
| $385K | ﹤0.01% |
8,200
-39,400
| -83% | -$2.16M |
|
Similar funds
Barclays's Q3 2014 Portfolio in Review
As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.
By sector, the portfolio is most concentrated in Healthcare at 5.5% of assets, up from 5% a quarter earlier, followed by Energy and Technology.
On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.
- Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
- Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
- Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
- Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
- Barclays opened 449 new positions and closed 388 in Q3 2014.
- Barclays's portfolio value rose 10% quarter-over-quarter to $104B.
Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.